Expression of apoptotic tumour necrosis factor receptor-associated factor, caspase recruitment domain and cell death-inducing DFF-45 effector genes in therapy-treated renal cell carcinoma
- PMID: 19076291
- DOI: 10.1111/j.1440-1797.2008.01027.x
Expression of apoptotic tumour necrosis factor receptor-associated factor, caspase recruitment domain and cell death-inducing DFF-45 effector genes in therapy-treated renal cell carcinoma
Abstract
Aim: Dysfunction in apoptosis plays a role in development of renal cell carcinoma (RCC). This investigation aimed to identify expression of apoptosis-related genes not previously characterized in human RCC.
Methods: The RCC ACHN cell line was treated with radiation plus interferon-alpha to induce significant apoptosis. Apoptosis RNA microarrays were used to compare control and treated RCC for apoptosis-regulatory genes with significantly altered expression (>or= twofold). Translational correlates were analysed using western blot. Immunohistochemistry of human RCC and non-cancerous kidney in tissue microarrays was also completed.
Results: Several gene families, not well characterized in RCC, were significantly upregulated in RNA microarray. These were the tumour necrosis factor receptor-associated factors (TRAF1, 3 and 4), caspase recruitment domain (NOL3 and PYCARD), and cell death-inducing DFF-45 effector domain (ICAD/CAD) genes. The protein expression patterns did not always increase similarly, perhaps indicating some post-transcriptional controls needing further investigation. TRAF1 had significantly increased expression for RNA and protein (P<0.01). NOL3 had significantly decreased whole-cell protein expression (P<0.05), but had strongly localized nuclear positivity in RCC in the immunohistochemistry.
Conclusion: These newly identified RCC apoptosis genes have shown potential for improving outcome in other cancers and may prove to have the same potential in RCC with further study.
Similar articles
-
Patient samples of renal cell carcinoma show reduced expression of TRAF1 compared with normal kidney and functional studies in vitro indicate TRAF1 promotes apoptosis: potential for targeted therapy.Pathology. 2012 Aug;44(5):453-9. doi: 10.1097/PAT.0b013e3283557748. Pathology. 2012. PMID: 22810054
-
In vitro enhanced cytotoxicity of tumor-infiltrating lymphocytes transfected with tumor necrosis factor-related apoptosis-inducing ligand and/or interleukin-2 gene in human renal cell carcinoma.Urology. 2006 May;67(5):1093-8. doi: 10.1016/j.urology.2005.11.030. Epub 2006 Apr 25. Urology. 2006. PMID: 16635513
-
Enhancement of Ad5-TRAIL cytotoxicity against renal cell carcinoma with histone deacetylase inhibitors.Cancer Gene Ther. 2006 Jun;13(6):628-32. doi: 10.1038/sj.cgt.7700939. Cancer Gene Ther. 2006. PMID: 16456549
-
Protein expression profiles in renal cell carcinoma: staging, prognosis, and patient selection for clinical trials.Clin Cancer Res. 2007 Jan 15;13(2 Pt 2):703s-708s. doi: 10.1158/1078-0432.CCR-06-1864. Clin Cancer Res. 2007. PMID: 17255297 Review.
-
[DNA and microRNA microarray technologies in diagnostics and prediction for patients with renal cell carcinoma].Klin Onkol. 2009;22(5):202-9. Klin Onkol. 2009. PMID: 19886357 Review. Czech.
Cited by
-
miR-214 Down-Regulation Promoted Hypoxia/Reoxygenation-Induced Hepatocyte Apoptosis Through TRAF1/ASK1/JNK Pathway.Dig Dis Sci. 2019 May;64(5):1217-1225. doi: 10.1007/s10620-018-5405-9. Epub 2018 Dec 17. Dig Dis Sci. 2019. PMID: 30560327
-
siRNA-mediated knock-down of DFF45 amplifies doxorubicin therapeutic effects in breast cancer cells.Cell Oncol (Dordr). 2013 Dec;36(6):515-26. doi: 10.1007/s13402-013-0157-1. Epub 2013 Nov 26. Cell Oncol (Dordr). 2013. PMID: 24277473
-
TXNDC5 is a cervical tumor susceptibility gene that stimulates cell migration, vasculogenic mimicry and angiogenesis by down-regulating SERPINF1 and TRAF1 expression.Oncotarget. 2017 Jun 29;8(53):91009-91024. doi: 10.18632/oncotarget.18857. eCollection 2017 Oct 31. Oncotarget. 2017. PMID: 29207620 Free PMC article.
-
MiR-145, a new regulator of the DNA fragmentation factor-45 (DFF45)-mediated apoptotic network.Mol Cancer. 2010 Aug 6;9:211. doi: 10.1186/1476-4598-9-211. Mol Cancer. 2010. PMID: 20687965 Free PMC article.
-
Role of apoptosis repressor with caspase recruitment domain in human health and chronic diseases.Ann Med. 2024 Dec;56(1):2409958. doi: 10.1080/07853890.2024.2409958. Epub 2024 Oct 1. Ann Med. 2024. PMID: 39351758 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous